Quadria Capital is Asia's leading healthcare private equity firm focussed on theme-driven growth investing. We partner with mid-size, high quality healthcare companies which have a potential to become regional leaders.

We consider ourselves as quasi strategic investors and aim to work with the companies by adding tangible value to help realise their vision. Quadria helps its portfolio companies execute the business plans and drive operational improvements in order to enhance performance metrics. In addition to benefiting our partners, the improvements in growth and operations benefit workers, communities and other stakeholders.


Leading hospital laboratory chain in Malaysia committed to enhancing the standards of care by delivering reliable and quality diagnostics services across Malaysia and the surrounding region
Strand Life Sciences

India’s Leading Integrated, Specialized Diagnostic Company With Strong Global Bioinformatics & Clinical Research Capabilities
Year of investment: 2018
Country: India
Sector: Healthcare Delivery
Status: Current Investment
Strand Life Sciences http://strandls.com

  • Established in 2000, Strand is one of India’s leading integrated, specialized diagnostic company and a
    leading provider of bioinformatics & research services globally
  • The company has end to end capabilities in precision medicine – assay development, proprietary
    analytics, clinical research, and genomic technologies.
  • The company offers comprehensive menu of specialised and routine tests through over 15
    laboratories in a mix of metros and emerging cities. It also operates the only CAP accredited genomics
    lab in South Asia
MWH Holdings

Singapore’s leading multi-specialty care group with core expertise in cardiology, ENT, gastroenterology, orthopaedics, urology and aesthetics, amongst others.
Year of investment: 2017
Country: Singapore
Sector: Associated Healthcare Services
Status: Current Investments

  • Founded by Ms. Wendy Huang and anchored by Chief Medical Officer and Asia’s renowned cardiologist, Dr. Michael Lim, with the support of a team of core doctors across multiple specialties
  • Strong reputation for providing high quality, complex clinical care, including being one of Asia’s pioneers in MR coronary imaging
  • Serves over 25,000 patients annually through its centers in Singapore’s two medical hubs (Paragon and Royal Square Novena), complemented by an asset-light business model for regional expansion
FV Hospital

Leading JCI accredited hospital providing high quality care to the population in Ho Chi Minh City and the surrounding region of South Vietnam
Year of investment: 2017
Country: Vietnam
Sector: Healthcare Delivery
Status: Current Investment

  • Founded by Dr. Jean-Marcel Guillon with a group of French physicians in 2003, FV Hospital has since evolved into a 220-bed full-service, one-stop provider of quality care for the local population in and around Ho Chi Minh City, Vietnam
  • First hospital in South Vietnam and one of only two hospitals in Vietnam to have received the JCI accreditation
  • Over 950 service staff, including 130 doctors, providing care across more than 30 medical specialties including Oncology, General Surgery, Joint Surgery, Gastroenterology and Maternity
Healthcare at HOME India

India’s leading integrated home healthcare service platform with core focus on providing clinical and pharma services to the patients in their homes
Year of investment: 2017
Country: India
Sector: Associated Healthcare Services
Status: Current Investment
Healthcare at HOME India https://hcah.in/

  • Healthcare at HOME is an integrated platform offering bouquet of healthcare delivery services and pharmaceutical services
  • In healthcare delivery services, the company offers high skill services such as ICU care, post-surgical care, and specialized nursing care at home to patients, as well as basic services such as physiotherapy and diagnostics. It also provides complex drug infusion and drug administration services for pharmaceutical companies.
  • Currently serves over 1,000 patients on a monthly basis for acute care services and manages over 35 patient access and patient support projects for pharmaceutical companies

Leading global supplier of fermentation based biopharma APIs focussed on niche segments like immunosuppressants and oncology
Year of investment: 2016
Country: India
Sector: Lifesciences
Status: Current Investment

  • Concord is one of India’s leading manufacturers of fermentation based niche biopharma APIs focussed on immunosuppressant, oncology, antifungal and antibacterial therapies
  • The Company has a product portfolio of 18 existing products across 8 therapeutic areas
  • Concord operates across both regulated (US, EU and Japan) and semi-regulated markets (LATAM, Africa, CIS and MENA)

One of South Asia’s leading gastric sciences hospital and amongst the 14 centres globally to be recognized as Centre of Excellence by World Endoscopy Organization
Year of investment: 2015
Country: India
Sector: Healthcare Delivery
Status: Current Investment

  • AIG is one of South Asia’s leading gastric sciences hospital treating over 130,000 patients each year and credited with performing the largest number of endoscopy procedures globally
  • It ranks amongst the 14 centres globally to be recognized as Centre of Excellence by World Endoscopy Organization
  • Constructing the world’s largest single location gastric sciences hospital

Leading integrated pharmaceuticals group in Indonesia, the fourth most populous country in the world with more than 250 million people
Year of investment: 2015
Country: Indonesia
Sector: Lifesciences
Status: Current Investment

  • SOHO is one of Indonesia’s largest integrated pharmaceutical businesses with leadership in OTC and healthcare distribution services, and a wide distribution network that covers over 70{3163b34706130b4e1cf64e8c1b910e982a843cab25723611cf66e26b48765851} of hospitals and pharmacies in Indonesia
  • It manufactures consumer and prescription products and is a market leader in the immunomodulator, laxative, anti-oxidant and children’s multivitamins space
  • SOHO has one of the widest marketing and distribution coverage platforms in Indonesia, covering over 21,000 doctors, representing over one-third of all doctors in Indonesia

Leading network of hospitals across East India with a presence across the region including the NABH/NABL accredited super specialty hospital in Kolkata
Year of investment: 2013
Country: India
Sector: Healthcare Delivery
Status: Current Investment
MEDICA SUPERSPECIALITY HOSPITAL http://www.medicahospitals.in

  • Medica is the largest hospital chain in eastern India, operating over 1,000 beds across 7 hospitals
  • Only private hospital group in eastern India with presence across four provinces and five cities
  • It provides 13 specialties and performs high-end procedures including open heart surgeries, knee and hip replacements, transplants and cardiology services

Specialist cancer care network headquartered in Bangalore, with dedicated cancer care services provided at 27 centres across India
Year of investment: 2010
Country: India
Sector: Healthcare Delivery
Status: Past Investment
HEALTHCARE GLOBAL ENTERPRISES LTD. http://www.hcgoncology.com

  • Super-specialty Oncology hospitals treating over 30,000 patients a year through its 19 cancer centers across India
  • The Company’s extensive pan-India presence with wide customer reach through an established hub and spoke business model has positioned it well to capture the large Indian market with over 3 million cancer patients
  • Named India’s best single-specialty hospital for 2013

One of South India’s largest healthcare network with a bed capacity of over 1,800 beds across 5 hospitals
Year of investment: 2009
Country: India
Sector: Healthcare Delivery
Status: Past Investment
KRISHNA INSTITUTE OF MEDICAL SCIENCE LTD. http://www.kimshospitals.com

  • One of the largest hospitals in Southern India with a total bed capacity of over 1800 beds across five super-specialty hospitals in the states of Telangana and Andhra Pradesh
  • Clinical excellence and leadership in key super-specialties such as cardiac sciences, orthopaedics and joint replacement, neurosciences, paediatrics and oncology